CYN · Cyngn Inc.

The reported transaction involved the Reporting Person's receipt of an annual grant of 72,000 restricted stock units. The 72,000 restricted stock units shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in continuous service on the vesting date. The total reported in Column 5 includes the (i) 72,000 newly awarded restricted stock units, (ii) 36,000 restricted stock units, of which all 36,000 have vested and issued to the Reporting Person, (ii) 32,609 restricted stock units, of which all 32,609 have vested and issued to the Reporting Person, (iii) 48,913 restricted stock units, of which 32,608 have vested and issued to the Reporting Person, and (iv) 1,250 shares of common stock.

The reported transaction involved the Reporting Person's receipt of an annual grant of 72,000 restricted stock units. The 72,000 restricted stock units shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in continuous service on the vesting date. The total reported in Column 5 includes the (i) 72,000 newly awarded restricted stock units, (ii) 36,000 restricted stock units, of which all 36,000 have vested and issued to the Reporting Person, (ii) 32,609 restricted stock units, of which all 32,609 have vested and issued to the Reporting Person, and (iii) 48,913 restricted stock units, of which 32,608 have vested and issued to the Reporting Person.

The reported transaction involved the Reporting Person's receipt of an annual grant of 72,000 restricted stock units. The 72,000 restricted stock units shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in continuous service on the vesting date. The total reported in Column 5 includes the (i) 72,000 newly awarded restricted stock units, (ii) 36,000 restricted stock units, of which all 36,000 have vested and issued to the Reporting person, (iii) 32,609 restricted stock units, of which all 32,609 have vested and issued to the Reporting Person, and (iv) 48,913 restricted stock units, of which 32,608 have vested and issued to the Reporting Person.

1/48th of the shares subject to the stock option will vest and become exercisable in monthly installments, commencing on the grant date.

1/48th of the shares subject to the stock option will vest and become exercisable in monthly installments, commencing on the grant date.

1/48th of the shares subject to the stock option will vest and become exercisable in monthly installments, commencing on the grant date.

The reported transaction involved the Reporting Person's receipt of an annual grant of 36,000 restricted stock units. The 36,000 restricted stock units shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in continuous service on the vesting date. The Reporting Person has reported prior annual awards of restricted stock in Table II of Form 4. The total reported in Column 5 includes the (i) 36,000 newly awarded restricted stock units, (ii) 32,609 restricted stock units previously reported in Table II, of which all 32,609 have vested and issued to the Reporting Person, (iii) 48,913 restricted stock units, of which 12,228 have vested and issued to the Reporting Person, and (iv) 1,250 shares of common stock.

The reported transaction involved the Reporting Person's receipt of an annual grant of 36,000 restricted stock units. The 36,000 restricted stock units shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in continuous service on the vesting date. The Reporting Person has reported prior annual awards of restricted stock in Table II of Form 4. The total reported in Column 5 includes the (i) 36,000 newly awarded restricted stock units, (ii) 32,609 restricted stock units previously reported in Table II, of which all 32,609 have vested and issued to the Reporting Person, and (iii) 48,913 restricted stock units, of which 12,228 have vested and issued to the Reporting Person.

The reported transaction involved the Reporting Person's receipt of an annual grant of 36,000 restricted stock units. The 36,000 restricted stock units shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in continuous service on the vesting date. The Reporting Person has reported prior annual awards of restricted stock in Table II of Form 4. The total reported in Column 5 includes the (i) 36,000 newly awarded restricted stock units, (ii) 32,609 restricted stock units previously reported in Table II, of which all 32,609 have vested and issued to the Reporting Person, (iii) 48,913 restricted stock units, of which 12,228 have vested and issued to the Reporting Person, and (iv) 1,250 shares of common stock.

The price reported in Column 4 represents the average price paid for the shares. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.257. Upon request by the Securities and Exchange Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

The total reported in Column 5 includes 48,913 RSUs, which represent a contingent right to receive one share of common stock for each RSU. The RSUs vest monthly in equal parts over a period of three years provided that the Reporting Person remains in continuous service on each vesting date. Of the 48,913 RSUs, 12,228 have vested and issued to the Reporting Person.

1/48th of the shares subject to the stock option will vest and become exercisable in monthly installments, commencing on the grant date.

1/48th of the shares subject to the stock option will vest and become exercisable in monthly installments, commencing on the grant date.

1/48th of the shares subject to the stock option will vest and become exercisable in monthly installments, commencing on the grant date.

Common Stock was issued to Reporting Person upon the exercise of stock options. The Reporting Person has no present intention to sell the shares of common stock acquired upon exercise of the stock options.

Common Stock was issued to Reporting Person upon the exercise of stock options. The Reporting Person has no present intention to sell the shares of common stock acquired upon exercise of the stock options.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The reported transaction involved the Reporting Person's receipt of 2,717 of the RSUs vested on July 13, 2022. Additional RSUs will vest monthly in equal parts over a period of three years provided that the Reporting Person remains in continuous service on each vesting date. The Reporting Person previously reported the award of the RSUs in Table II of Form 4. The total reported in Column 5 includes 48,913 RSUs previously reported in Table II, of which 2,717 have vested and issued to the Reporting Person.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The reported transaction involved the Reporting Person's receipt of 2,717 of the RSUs vested on July 13, 2022. Additional RSUs will vest monthly in equal parts over a period of three years provided that the Reporting Person remains in continuous service on each vesting date. The Reporting Person previously reported the award of the RSUs in Table II of Form 4. The total reported in Column 5 includes 48,913 RSUs previously reported in Table II, of which 2,717 have vested and issued to the Reporting Person.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The reported transaction involved the Reporting Person's receipt of 2,717 of the RSUs vested on July 13, 2022. Additional RSUs will vest monthly in equal parts over a period of three years provided that the Reporting Person remains in continuous service on each vesting date. The Reporting Person previously reported the award of the RSUs in Table II of Form 4. The total reported in Column 5 includes 48,913 RSUs previously reported in Table II, of which 2,717 have vested and issued to the Reporting Person.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs shall vest monthly in equal parts over a period of three years beginning on June 1, 2022 provided that the Reporting Person remains in continuous service on each vesting date.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs shall vest monthly in equal parts over a period of three years beginning on June 1, 2022 provided that the Reporting Person remains in continuous service on each vesting date.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in service on the vesting date.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in service on the vesting date.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs shall vest in its entirety one year from the date of grant provided that the Reporting Person remains in service on the vesting date.

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs shall vest monthly in equal parts over a period of three years beginning on June 1, 2022 provided that the Reporting Person remains in continuous service on each vesting date.

Common Stock was issued to Reporting Person upon the exercise of stock options. The Reporting Person has no present intention to sell the shares of common stock acquired upon exercise of the stock options.

Common Stock was issued to Reporting Person upon the exercise of stock options. The Reporting Person has no present intention to sell the shares of common stock acquired upon exercise of the stock options.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

The shares of Preferred Stock automatically converted into shares of the Company's Common Stock immediately prior to the consummation of the Company's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.

Redpoint Ventures IV, LLC ("RV IV LLC") is the sole general partner of Redpoint Ventures IV, L.P. ("RV IV"). RV IV LLC and Redpoint Associates IV, LLC ("RA IV") are under common control. As such, RV IV LLC has sole voting and investment control over the shares owned by RV IV, and may be deemed to beneficially own the shares held by RV IV. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

These shares of Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Issuer's initial public offering.

These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III") is the general partner of the AH Fund III Entities and has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

The shares of Preferred Stock automatically converted into shares of the Company's Common Stock immediately prior to the consummation of the Company's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

The shares of Preferred Stock automatically converted into shares of the Company's Common Stock immediately prior to the consummation of the Company's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

The shares of Preferred Stock automatically converted into shares of the Company's Common Stock immediately prior to the consummation of the Company's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.

Redpoint Ventures IV, LLC ("RV IV LLC") is the sole general partner of Redpoint Ventures IV, L.P. ("RV IV"). RV IV LLC and Redpoint Associates IV, LLC ("RA IV") are under common control. As such, RV IV LLC has sole voting and investment control over the shares owned by RV IV, and may be deemed to beneficially own the shares held by RV IV. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.

The shares of Preferred Stock automatically converted into shares of the Company's Common Stock immediately prior to the consummation of the Company's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.

The shares of Preferred Stock automatically converted into shares of the Company's Common Stock immediately prior to the consummation of the Company's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.

Redpoint Ventures IV, LLC ("RV IV LLC") is the sole general partner of Redpoint Ventures IV, L.P. ("RV IV"). RV IV LLC and Redpoint Associates IV, LLC ("RA IV") are under common control. As such, RV IV LLC has sole voting and investment control over the shares owned by RV IV, and may be deemed to beneficially own the shares held by RV IV. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.

These shares of Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Issuer's initial public offering.

These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III") is the general partner of the AH Fund III Entities and has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

These shares of Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Issuer's initial public offering.

These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III") is the general partner of the AH Fund III Entities and has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VII, L.P. ("BCP VII"), for itself and as nominee for Benchmark Founders' Fund VII, L.P. ("BFF VII") and Benchmark Founders' Fund VII-B, L.P. ("BFF VII-B"). Benchmark Capital Management Co. VII, L.L.C. ("BCMC VII"), the general partner of each of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole voting and dispositive power over such shares. Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VII, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person's or entity's pecuniary interest in such securities.

All Series of convertible Preferred Stock automatically converted into shares of the Company's Common Stock on a 1-for-1 basis, without payment or further consideration, immediately prior to the consummation of the Company's initial public offering.

The shares are held by Benchmark Capital Partners VI, L.P. ("BCP VI"), for itself and as nominee for Benchmark Founders' Fund VI, L.P. ("BFF VI"), Benchmark Founders' Fund VI-B, L.P. ("BFF VI-B") and related persons. Benchmark Capital Management Co. VI, L.L.C. ("BCMC VI"), the general partner of each of BCP VI, BFF VI and BFF VI-B, may be deemed to have sole voting and dispositive power over such shares. Alexandre Balkanski, Matthew R. Cohler, Bruce W. Dunlevie, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Robert C. Kagle, Mitchell H. Lasky (a member of the Issuer's board of directors) and Steven M. Spurlock, the managing members of BCMC VI, may be deemed to share voting and dispositive power over these shares beneficially held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of any securities, except to the extent of such person or entity's pecuniary interest in such securities.

The shares of Preferred Stock automatically converted into shares of the Company's Common Stock immediately prior to the consummation of the Company's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.